However, while Wegovy and Saxenda target just GLP-1 receptors, Zepbound is considered a dual agonist, meaning it targets GLP-1 receptors and the receptors for the hormone GIP
Potential Side Effects While generally safe, some users may experience: Nausea & Vomiting (common at the beginning) Diarrhea or Constipation Fatigue Low Blood Sugar (Hypoglycemia) Injection Site Reactions If severe side effects occur, consult your healthcare provider immediately
Health Canadas performance framework replaces older indicators tied to overall national drug spending with a new measure of pharmaceutical spending per capita, projected to fall between $1,212 and $1,340 by 202627
doi: 10.1001/jama.2022.0078 [DOI] [PMC free article] [PubMed] [Google Scholar] 89.Inagaki N, Takeuchi M, Oura T, et al